Michael N. Vranian

566 total citations
13 papers, 370 citations indexed

About

Michael N. Vranian is a scholar working on Molecular Biology, Nephrology and Oncology. According to data from OpenAlex, Michael N. Vranian has authored 13 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Nephrology and 4 papers in Oncology. Recurrent topics in Michael N. Vranian's work include Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), Parathyroid Disorders and Treatments (4 papers) and Peptidase Inhibition and Analysis (3 papers). Michael N. Vranian is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), Parathyroid Disorders and Treatments (4 papers) and Peptidase Inhibition and Analysis (3 papers). Michael N. Vranian collaborates with scholars based in United States and Brazil. Michael N. Vranian's co-authors include Brett W. Sperry, Mazen Hanna, Rory Hachamovitch, Asad Ikram, Dermot Phelan, Jason Valent, Richard C. Brunken, Wael A. Jaber, Albree Tower‐Rader and Manuel D. Cerqueira and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and JACC. Cardiovascular imaging.

In The Last Decade

Michael N. Vranian

13 papers receiving 362 citations

Peers

Michael N. Vranian

NEPHR

ONCOL

CCM

PHYSI

Jeremy Slivnick United States

Young‐Il Jo South Korea

Chiara Arzilli Italy

Naznin Dixit United States

Scott Morris United Kingdom

Wenjing Chen China

Hongyan Mo China

Nikhil Nair United States

Lele Cheng China

Barbara Guisan Switzerland

Jeremy Slivnick United States

Michael N. Vranian

116 ×0.4

46 ×0.3

NEPHR

27 ×0.3

ONCOL

196 ×2.4

CCM

48 ×0.7

PHYSI

Citations per year, relative to Michael N. Vranian Michael N. Vranian (= 1×) peers Jeremy Slivnick

Countries citing papers authored by Michael N. Vranian

Since Specialization

Citations

This map shows the geographic impact of Michael N. Vranian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael N. Vranian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael N. Vranian more than expected).

Fields of papers citing papers by Michael N. Vranian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael N. Vranian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael N. Vranian. The network helps show where Michael N. Vranian may publish in the future.

Co-authorship network of co-authors of Michael N. Vranian

This figure shows the co-authorship network connecting the top 25 collaborators of Michael N. Vranian. A scholar is included among the top collaborators of Michael N. Vranian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael N. Vranian. Michael N. Vranian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Jacob, Ron, et al.. (2024). Case report of entrectinib associated fulminant myocarditis. European Heart Journal - Case Reports. 9(1). ytae650–ytae650. 5 indexed citations

Vranian, Michael N., Brett W. Sperry, Mazen Hanna, et al.. (2017). Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: Associations with echocardiographic disease severity and outcomes. Journal of Nuclear Cardiology. 25(4). 1247–1256. 30 indexed citations

Sperry, Brett W., Michael N. Vranian, Albree Tower‐Rader, et al.. (2017). Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality. JACC. Cardiovascular imaging. 11(2). 234–242. 67 indexed citations

Ikram, Asad, Brett W. Sperry, Michael N. Vranian, et al.. (2016). EFFICACY OF CHEMOTHERAPY IN LIGHT CHAIN AMYLOIDOSIS IN PATIENTS PRESENTING WITH SYMPTOMATIC HEART FAILURE. Journal of the American College of Cardiology. 67(13). 1285–1285. 1 indexed citations

Sperry, Brett W., et al.. (2016). Are classic predictors of voltage valid in cardiac amyloidosis? A contemporary analysis of electrocardiographic findings. International Journal of Cardiology. 214. 477–481. 53 indexed citations

Sperry, Brett W., Asad Ikram, Rory Hachamovitch, et al.. (2016). Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart Failure. Journal of the American College of Cardiology. 67(25). 2941–2948. 71 indexed citations

Sperry, Brett W., Michael N. Vranian, Albree Tower‐Rader, et al.. (2016). Apical Sparing Left and Right Ventricular Uptake of Technetium Pyrophosphate in Transthyretin Cardiac Amyloidosis. 57. 172–172. 1 indexed citations

Sperry, Brett W., Michael N. Vranian, Rory Hachamovitch, et al.. (2016). Subtype‐Specific Interactions and Prognosis in Cardiac Amyloidosis. Journal of the American Heart Association. 5(3). e002877–e002877. 46 indexed citations

Vranian, Michael N., Brett W. Sperry, Jason Valent, & Mazen Hanna. (2015). Emerging Advances in the Management of Cardiac Amyloidosis. Current Cardiology Reports. 17(11). 100–100. 20 indexed citations

10.

Hill, Terence E., et al.. (2015). Management of life-threatening flecainide overdose: A case report and review of the literature. HeartRhythm Case Reports. 2(3). 228–231. 23 indexed citations

11.

Vranian, Michael N., Tanya E. Keenan, Michael J. Blaha, et al.. (2013). Impact of Fitness Versus Obesity on Routinely Measured Cardiometabolic Risk in Young, Healthy Adults. The American Journal of Cardiology. 111(7). 991–995. 10 indexed citations

12.

Vranian, Michael N., Michael J. Blaha, Michael G. Silverman, et al.. (2012). THE INTERACTION OF FITNESS, FATNESS, AND CARDIOMETABOLIC RISK. Journal of the American College of Cardiology. 59(13). E1754–E1754. 7 indexed citations

13.

Farthing, Don, Domenic A. Sica, Itaf Fakhry, et al.. (2005). Simple HPLC–UV method for determination of iohexol, iothalamate, p-aminohippuric acid and n-acetyl-p-aminohippuric acid in human plasma and urine with ERPF, GFR and ERPF/GFR ratio determination using colorimetric analysis. Journal of Chromatography B. 826(1-2). 267–272. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact